Lion's ManevsReishi

Lion's Mane contains two classes of bioactive compounds: hericenones (A-H, found in the fruiting body) and erinacines (A-I, found in the mycelium). Both stimulate the synthesis of nerve growth factor (NGF) in astrocytes and neurons — hericenones may act through enhancement of NGF gene expression, while erinacines cross the blood-brain barrier and directly induce NGF. NGF binds to TrkA receptors and is essential for the survival, maintenance, and regeneration of cholinergic neurons, particularly in the hippocampus and basal forebrain. This promotes neurogenesis, dendritic arborization, and remyelination of nerve fibers. Lion's Mane also reduces neuroinflammation through inhibition of NF-κB signaling and suppression of pro-inflammatory cytokine production. It may enhance BDNF expression and support the gut-brain axis.

Reishi's triterpenes (ganoderic acids A, C, D, H; ganoderenic acids) modulate the HPA axis by reducing CRH and ACTH release, lowering cortisol via glucocorticoid receptor feedback. Ganoderic acids have direct sedative effects through GABA-A receptor modulation (possibly allosteric at the benzodiazepine site) and 5-HT2A/2C serotonergic modulation. Beta-(1,3)-(1,6)-glucan polysaccharides bind Dectin-1 and complement receptor 3 (CR3) on macrophages, natural killer cells, and dendritic cells, activating NF-kB and MAPK signaling for immune modulation. Reishi inhibits histamine release from mast cells via Fc epsilon RI downregulation and stabilizes mast cell membranes (anti-allergic effect). Antioxidant properties involve upregulation of superoxide dismutase (SOD1/SOD2), catalase, and glutathione peroxidase. Ganoderic acids may also inhibit 5-alpha-reductase and ACE.